← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2015Last known activity
Nov 29, 2023
Acquired by Novo Nordisk on Sep 1, 2022
Timeline
2000s
- Jun 1, 2008
Forma Therapeutics, Inc.— Founded
2020s
- Sep 1, 2022
Novo Nordisk— Acquired By
Drugs by trial phase (12 distinct, 13 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT05725902Lead sponsorPhase 2Nov 29, 2023
- NCT05725902Study directorPhase 2Nov 29, 2023
- NCT05953584Lead sponsorPhase 2Jun 20, 2023
- NCT06198712Lead sponsorPhase 1/Phase 2Feb 7, 2023
- NCT05568225Lead sponsorPhase 2Nov 22, 2022
- NCT05568225Study directorPhase 2Nov 22, 2022
- NCT04987489Lead sponsorPhase 2Sep 30, 2021
- NCT04987489Study directorPhase 2Sep 30, 2021
- NCT04624659Study directorPhase 2/Phase 3Dec 31, 2020
- NCT04624659Lead sponsorPhase 2/Phase 3Dec 31, 2020
- NCT04575766Study directorPhase 1Nov 30, 2020
- NCT04575766Lead sponsorPhase 1Nov 30, 2020
- NCT04013880CollaboratorPhase 1/Phase 2Aug 31, 2019
- NCT04004325Lead sponsorPhase 1/Phase 2May 17, 2019
- NCT04004325Study directorPhase 1/Phase 2May 17, 2019
Details
- Founded
- Cambridge, MA, US Jun 1, 2008
- Last known activity
- Nov 29, 2023